NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/05/2026
Voltar para busca
Dado oficial do USPTO
CELLTOLERANCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CELLTOLERANCE
ST13
US500000079408132Classe
42, 44
Pedido
79408132
Registro
8268362
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
26/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
22/07/2024
Data de registro
26/05/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/05/2026
Última transação
26/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
33
Localização do titular
FR
Examinador
BLAKESLEE, RICHARD A
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
M. T. (pessoa física)
Representantes
Jeff Goehring Nixon & Vanderhye P.C.
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological servicesscientific research and design services in the field of diagnostic tools for medical applications; Development of new technology on behalf of third parties in the field of biotechnology; providing information relating to medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; scientific research and development in the field of pharmaceuticals and biotechnology; analyzingassessing and reporting diagnostic test results and diagnostic or prognostic tests of residual disease to assist healthcare professionals in the clinical diagnosis of a patientto assess the effectiveness of treatments prescribed to patients and change future treatments accordingly; medical and scientific research in the field of treatment and diagnosis of digestive and gastrointestinal diseases and disorders
Classe 44
Health care services for human beingsnamely gastrointestinal health care services; medical analysis services relating to the treatment of patients; medical services for the remote analysis of optical samples and diagnosis on cells; medical services relating to the collectiontreatment and processing of human cells; medical assessment of health status for medical diagnostic purposes; medical diagnosis servicesmedical diagnosis of digestive disorders; medical diagnostic and testing services in relation to digestive and gastrointestinal diseases and disorders; medical testing services for diagnostic or treatment purposes; health care management in the nature of developing care protocols in relation to digestive and gastrointestinal diseases and disorders; providing news and information in the field of medicine; provision of information relating to medical services; provision of medical information in the field of health; providing medical information in the field of gastroenterology; individual medical advisory services provided to patients; medical testing services for the diagnosis and treatment of persons
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
26/05/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/04/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2026
PUBO
PUBLISHED FOR OPPOSITION
07/04/2026
GPNX
NOTIFICATION PROCESSED BY IB
02/04/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/03/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/03/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/03/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
11/03/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
22/08/2025
GNFR
FINAL REFUSAL E-MAILED
22/08/2025
CNFR
FINAL REFUSAL WRITTEN
22/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/08/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/08/2025
RFNT
REFUSAL PROCESSED BY IB
22/03/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/03/2025
RFRR
REFUSAL PROCESSED BY MPU
04/03/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/01/2025
CNRT
NON-FINAL ACTION WRITTEN
15/01/2025
DOCK
ASSIGNED TO EXAMINER
08/01/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/11/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/11/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/10/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLTOLERANCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.